-
The ink dry lotus market is like a roller coaster, who is at fault?
Time of Update: 2022-10-14
2, high prices to stimulate wild harvest Due to the perennial low price, wild resources are relatively rich, farmers generally harvest in the year, in 2021 Henan is affected by floods, the yield is greatly reduced, coupled with weak inventory led to a sharp rise in the market of ink dry lotus.
-
UK Bureau of Home Statistics: The rate of COVID-19 infection has risen in many parts of the UK
Time of Update: 2022-10-13
hospitals According to the National Bureau of Statistics, the rate of new crown virus infection in England continues to rise, the rate of infection in North Ireland has increased, and the trend of infection in Wales and Scotland is currently unclear.
-
Faucci: The United States may see a more dangerous new variant of the new coronavirus this winter
Time of Update: 2022-10-13
According to the US Consumer News and Business Channel (CNBC), on the 7th local time, Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said that a more dangerous new coronavirus variant may appear in the coming winter.
-
WHO warns India to test cough syrup exported by a pharmaceutical company
Time of Update: 2022-10-13
Reuters quoted India's Ministry of Health as reporting that the syrup samples exported to the Gambia have been sent back to Indian laboratories for testing, and the government will take follow-up measures based on the test results.
-
UK Health and Security: This winter is likely to be at risk of a combination of COVID-19 and flu
Time of Update: 2022-10-13
” The British Health Safety Agency recently issued a communiqué saying that the British public may face the dual risk of widespread influenza transmission and a surge in new crown infection this winter, calling on the public to vaccinate two vaccines in time.
-
The British health department is worried about the serious epidemic in autumn and winter, and the daily increase in confirmed cases in Japan is declining
Time of Update: 2022-10-13
(End) Statistics from Johns Hopkins University in the United States show that as of 8:23 Beijing time on October 3, the cumulative number of confirmed covid-19 cases in the world 618036490, and the cumulative number of deaths 6546797.
-
The German healthcare sector will grow significantly in 2021
Time of Update: 2022-10-13
(End) According to the German Federal Ministry of Economy and Climate Protection on the 7th, the 2021 German Healthcare Industry Economic Accounting (GGR) data commissioned by the Ministry of Economics Research Institute WifOR shows that the German healthcare industry will grow significantly in 2021.
-
Multiple states in the United States reported E. coli infection and the health department launched an investigation
Time of Update: 2022-10-13
coli infections in multiple states, and said that this may be related to the frozen salad sandwiches sold by food chain Oleqi (ALDI).
coli infections in multiple states, and said that this may be related to the frozen salad sandwiches sold by food chain Oleqi (ALDI).
-
Under the national high priority in the development of environmental protection industry, the pharmaceutical equipment industry will usher in more opportunities and challenges
Time of Update: 2022-10-12
【Pharmaceutical Network Market Analysis】Recently, in order to standardize and guide the environmental management of waste sulfuric acid utilization and disposal, the Ministry of Ecology and Environmen
-
The pharmaceutical sector has changed again, and many individual stocks have closed 2 consecutive boards!
Time of Update: 2022-10-12
Longjin Pharmaceutical is a pharmaceutical company engaged in the research and development, production and sales of modern traditional Chinese medicine and characteristic chemical generic drugs.
Longjin Pharmaceutical is a pharmaceutical company engaged in the research and development, production and sales of modern traditional Chinese medicine and characteristic chemical generic drugs.
-
The pharmaceutical sector has reappeared in the rising tide, and one stock has risen and stopped 25 times in the past year
Time of Update: 2022-10-12
The company's main products are Longjin injection of calendulain, is a high-purity Chinese medicine lyophilized powder injection, the product has the effect of activating blood stasis, through the network and analgesia, used for the treatment of cardiovascular and cerebrovascular diseases, mainly used for the treatment of stroke and its sequelae, coronary heart disease, angina.
-
The domestic 4 trillion biomedical market has entered the "awakening era"
Time of Update: 2022-10-12
【Pharmaceutical Network Market Analysis】 In recent years, with the continuous introduction of favorable policies for biomedicine, the biomedical industry has achieved rapid development.
【Pharmaceutical Network Market Analysis】 In recent years, with the continuous introduction of favorable policies for biomedicine, the biomedical industry has achieved rapid development.
-
Chinese families often prepare cold medicine Lianhua Qingfeng
Time of Update: 2022-10-12
The family often has cold medicine even flowers to clear the plague Seemingly ordinary and common colds, if you choose the wrong cold medicine, it will delay the condition and even cause complication
-
The pharmaceutical equipment industry is supported by local policies and accelerates its development to the middle and high-end
Time of Update: 2022-10-12
Although the peak period brought by vaccines has gone, pharmaceutical equipment is in the upstream of the life science industry, and the industry generally believes that with the continuous improvement of the performance of domestic pharmaceutical machine products and the acceleration of the transformation to the middle and high-end, the market opportunity of domestic substitution is still an important opportunity period for pharmaceutical machine enterprises.
-
Pharmaceutical stocks erupt en masse! Subdivisions such as traditional Chinese medicine and medical devices have strengthened
Time of Update: 2022-10-12
The bank believes that with the control of the epidemic, the performance of the pharmaceutical industry in the third quarter is expected to achieve accelerated growth, and in the medium and long term, pay attention to the basic aspects of the post-epidemic period.
-
Pharmaceutical companies have entered the adjustment period, and several major segments are still receiving attention!
Time of Update: 2022-10-12
【Pharmaceutical Network Market Analysis】Affected by the epidemic, collection and other factors, the downward pressure on the pharmaceutical industry has begun, most pharmaceutical companies have a har
-
Following the two consecutive boards, this pharmaceutical stock has opened the limit again!
Time of Update: 2022-10-12
The actual controllers of the Company, Yu Chunming and Yu Chaobiao, have signed the Share Transfer Agreement on Anhui Huangshan Capsule Co.
The actual controllers of the Company, Yu Chunming and Yu Chaobiao, have signed the Share Transfer Agreement on Anhui Huangshan Capsule Co.
-
From 10,000 yuan to 1,000 yuan, the orthopedic spine consumables market may face a reshuffle
Time of Update: 2022-10-12
In the secondary market, some orthopedic listed companies were affected by the results of the collection, and the stock price rose by more than 10% on the same day, which fully reflected the market's better expectations for the industry.
-
The upgrading and transformation of traditional Chinese medicine enterprises has accelerated, and a large number of enterprises are focusing on the big health industry
Time of Update: 2022-10-12
On January 19 this year, Tailong Pharmaceutical also announced that the company intends to invest 50 million yuan to set up a wholly-owned subsidiary in Yunnan.
On January 19 this year, Tailong Pharmaceutical also announced that the company intends to invest 50 million yuan to set up a wholly-owned subsidiary in Yunnan.
-
Generic drug competition continues to intensify, how should pharmaceutical companies avoid "internal rolls"
Time of Update: 2022-10-12
For example, Hengrui, which has increased R&D investment and bet on innovative drugs in recent years, by the end of 2021, 10 innovative drugs have been approved for listing in China, more than 60 innovative drugs are under clinical development, and more than 250 clinical trials have been carried out at home and abroad.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
